PUBLISHER: KBV Research | PRODUCT CODE: 1373978
PUBLISHER: KBV Research | PRODUCT CODE: 1373978
North America Drug Eluting Stent Market Size, Share & Industry Trends Analysis Report By Application (Coronary Artery Disease, and Peripheral Artery Disease), By Coating Type, By Country and Growth Forecast, 2023 - 2030
The North America Drug Eluting Stent Market would witness market growth of 7.2% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 3,399.3 thousand units, showcasing a growth of 6.9% (2019-2022).
Stents are employed in operations like coronary angioplasty. Percutaneous coronary interventions (PCI), other coronary angioplasty procedures, and the therapy of coronary artery disease involve drug-eluting stents (DES). Three components comprise a drug eluting stent: the stent platform, the polymer coating (which keeps the medication inside the stent), and the drug itself. The danger of acquiring artery diseases rises with the aging population, increasing the need for efficient treatment alternatives like drug eluting stents.
The prevalence of atherosclerosis, defined by plaque development in the arteries, has increased due to sedentary lifestyles and poor dietary practices. Heart attacks and strokes, among other cardiovascular disorders, are considerably exacerbated by this disease. Due to this growing public health hazard, drug eluting stents are becoming more popular among medical professionals as a preferred method of treating atherosclerosis.
Additionally, reducing patient problems and the number and length of hospital stays have received significant attention as the healthcare industry reforms to switch from the present fee-for-service model to a fee-for-value model. Particularly in interventional cardiology, there has been a considerable evolution in device technology, operator techniques, clinical safety, and efficacy. Huge strides have been made in treating coronary artery disease, and patients today live in the era of "stent implantation."
Canada has also seen many cases of heart disease in recent years. Approximately 1 in 12 (or 2.6 million) Canadian adults age 20 and over have been diagnosed with heart disease, and every hour, roughly 14 Canadian adults age 20 and over with this diagnosis pass away, according to 2017-2018 statistics from the Canadian Chronic Disease Surveillance System (CCDSS). Likewise, the aging population is also a concern. According to the Government of Canada, over 861,000 older adults, or more than twice as many as were found in the 2001 Census, were counted in the 2021 Census. With a 12% increase over 2016, the population of people aged 85 and beyond is one of the age groups with the most significant growth. At the moment, 2.3% of people are 85 years of age or older. The abovementioned factors will present lucrative prospects for drug eluting stents in North America.
The US market dominated the North America Drug Eluting Stent Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $3,570.1 million by 2030. The Canada market is experiencing a CAGR of 9.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 8.7% during (2023 - 2030).
Based on Application, the market is segmented into Coronary Artery Disease, and Peripheral Artery Disease. Based on Coating Type, the market is segmented into Polymer-based Coating (Non-biodegradable Polymers, and Biodegradable Polymers), and Polymer-free Coating (Micro Porous Surface, Micro Structured Surface, Slotted Tubular Surface, and Nanoporous Surface). Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Medtronic PLC, Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.), Cook Medical, Inc. (Cook Group), B. Braun Melsungen AG, Biotronik SE & Co. KG, Lepu Medical Technology Co., Ltd and Alvimedica
Scope of the Study
Market Segments covered in the Report:
By Application (Volume, Thousand Units, USD Million, 2019-2030)
- Coronary Artery Disease
- Peripheral Artery Disease
By Coating Type (Volume, Thousand Units, USD Million, 2019-2030)
- Polymer-based Coating
- Non-biodegradable Polymers
- Biodegradable Polymers
- Polymer-free Coating
- Micro Porous Surface
- Micro Structured Surface
- Slotted Tubular Surface
- Nanoporous Surface
By Country (Volume, Thousand Units, USD Million, 2019-2030)
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Abbott Laboratories
- Boston Scientific Corporation
- Terumo Corporation
- Medtronic PLC
- Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.)
- Cook Medical, Inc. (Cook Group)
- B. Braun Melsungen AG
- Biotronik SE & Co. KG
- Lepu Medical Technology Co., Ltd
- Alvimedica
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Drug Eluting Stent Market, by Application
- 1.4.2 North America Drug Eluting Stent Market, by Coating Type
- 1.4.3 North America Drug Eluting Stent Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market At a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter's Five Force Analysis
Chapter 4. North America Drug Eluting Stent Market by Application
- 4.1 North America Coronary Artery Disease Market by Country
- 4.2 North America Peripheral Artery Disease Market by Country
Chapter 5. North America Drug Eluting Stent Market by Coating Type
- 5.1 North America Polymer-based Coating Market by Country
- 5.2 North America Drug Eluting Stent Market by Polymer-based Coating Type
- 5.2.1 North America Non-biodegradable Polymers Market by Country
- 5.2.2 North America Biodegradable Polymers Market by Country
- 5.3 North America Polymer-free Coating Market by Country
- 5.4 North America Drug Eluting Stent Market by Polymer-free Coating Type
- 5.4.1 North America Micro Porous Surface Market by Country
- 5.4.2 North America Micro Structured Surface Market by Country
- 5.4.3 North America Slotted Tubular Surface Market by Country
- 5.4.4 North America Nanoporous Surface Market by Country
Chapter 6. North America Drug Eluting Stent Market by Country
- 6.1 US Drug Eluting Stent Market
- 6.1.1 US Drug Eluting Stent Market by Application
- 6.1.2 US Drug Eluting Stent Market by Coating Type
- 6.1.2.1 US Drug Eluting Stent Market by Polymer-based Coating Type
- 6.1.2.2 US Drug Eluting Stent Market by Polymer-free Coating Type
- 6.2 Canada Drug Eluting Stent Market
- 6.2.1 Canada Drug Eluting Stent Market by Application
- 6.2.2 Canada Drug Eluting Stent Market by Coating Type
- 6.2.2.1 Canada Drug Eluting Stent Market by Polymer-based Coating Type
- 6.2.2.2 Canada Drug Eluting Stent Market by Polymer-free Coating Type
- 6.3 Mexico Drug Eluting Stent Market
- 6.3.1 Mexico Drug Eluting Stent Market by Application
- 6.3.2 Mexico Drug Eluting Stent Market by Coating Type
- 6.3.2.1 Mexico Drug Eluting Stent Market by Polymer-based Coating Type
- 6.3.2.2 Mexico Drug Eluting Stent Market by Polymer-free Coating Type
- 6.4 Rest of North America Drug Eluting Stent Market
- 6.4.1 Rest of North America Drug Eluting Stent Market by Application
- 6.4.2 Rest of North America Drug Eluting Stent Market by Coating Type
- 6.4.2.1 Rest of North America Drug Eluting Stent Market by Polymer-based Coating Type
- 6.4.2.2 Rest of North America Drug Eluting Stent Market by Polymer-free Coating Type
Chapter 7. Company Profiles
- 7.1 Abbott Laboratories
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 Recent strategies and developments:
- 7.1.5.1 Mergers & Acquisition:
- 7.1.6 SWOT Analysis
- 7.2 Boston Scientific Corporation
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expense
- 7.2.5 SWOT Analysis
- 7.3 Terumo Corporation
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 Research & Development Expenses
- 7.3.5 Recent strategies and developments:
- 7.3.5.1 Partnerships, Collaborations & Agreements:
- 7.3.6 SWOT Analysis
- 7.4 Medtronic PLC
- 7.4.1 Company overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expenses
- 7.4.5 Recent strategies and developments:
- 7.4.5.1 Trials and Approvals:
- 7.4.5.2 Product Launches and Product Expansions:
- 7.4.6 SWOT Analysis
- 7.5 Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.)
- 7.5.1 Company Overview
- 7.5.2 Recent strategies and developments:
- 7.5.2.1 Trials and Approvals:
- 7.5.3 SWOT Analysis
- 7.6 Cook Medical, Inc. (Cook Group)
- 7.6.1 Company Overview
- 7.6.2 SWOT Analysis
- 7.7 B. Braun Melsungen AG
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expenses
- 7.7.5 SWOT Analysis
- 7.8 Biotronik SE & Co. KG
- 7.8.1 Company Overview
- 7.8.2 SWOT Analysis
- 7.9 Lepu Medical Technology Co., Ltd
- 7.9.1 Company Overview
- 7.9.2 SWOT Analysis
- 7.10. Alvimedica
- 7.10.1 Company Overview
- 7.10.2 SWOT Analysis
LIST OF TABLES
- TABLE 1 North America Drug Eluting Stent Market, 2019 - 2022, USD Million
- TABLE 2 North America Drug Eluting Stent Market, 2023 - 2030, USD Million
- TABLE 3 North America Drug Eluting Stent Market, 2019 - 2022, Thousand Units
- TABLE 4 North America Drug Eluting Stent Market, 2023 - 2030, Thousand Units
- TABLE 5 North America Drug Eluting Stent Market by Application, 2019 - 2022, USD Million
- TABLE 6 North America Drug Eluting Stent Market by Application, 2023 - 2030, USD Million
- TABLE 7 North America Drug Eluting Stent Market by Application, 2019 - 2022, Thousand Units
- TABLE 8 North America Drug Eluting Stent Market by Application, 2023 - 2030, Thousand Units
- TABLE 9 North America Coronary Artery Disease Market by Country, 2019 - 2022, USD Million
- TABLE 10 North America Coronary Artery Disease Market by Country, 2023 - 2030, USD Million
- TABLE 11 North America Coronary Artery Disease Market by Country, 2019 - 2022, Thousand Units
- TABLE 12 North America Coronary Artery Disease Market by Country, 2023 - 2030, Thousand Units
- TABLE 13 North America Peripheral Artery Disease Market by Country, 2019 - 2022, USD Million
- TABLE 14 North America Peripheral Artery Disease Market by Country, 2023 - 2030, USD Million
- TABLE 15 North America Peripheral Artery Disease Market by Country, 2019 - 2022, Thousand Units
- TABLE 16 North America Peripheral Artery Disease Market by Country, 2023 - 2030, Thousand Units
- TABLE 17 North America Drug Eluting Stent Market by Coating Type, 2019 - 2022, USD Million
- TABLE 18 North America Drug Eluting Stent Market by Coating Type, 2023 - 2030, USD Million
- TABLE 19 North America Drug Eluting Stent Market by Coating Type, 2019 - 2022, Thousand Units
- TABLE 20 North America Drug Eluting Stent Market by Coating Type, 2023 - 2030, Thousand Units
- TABLE 21 North America Polymer-based Coating Market by Country, 2019 - 2022, USD Million
- TABLE 22 North America Polymer-based Coating Market by Country, 2023 - 2030, USD Million
- TABLE 23 North America Polymer-based Coating Market by Country, 2019 - 2022, Thousand Units
- TABLE 24 North America Polymer-based Coating Market by Country, 2023 - 2030, Thousand Units
- TABLE 25 North America Drug Eluting Stent Market by Polymer-based Coating Type, 2019 - 2022, USD Million
- TABLE 26 North America Drug Eluting Stent Market by Polymer-based Coating Type, 2023 - 2030, USD Million
- TABLE 27 North America Non-biodegradable Polymers Market by Country, 2019 - 2022, USD Million
- TABLE 28 North America Non-biodegradable Polymers Market by Country, 2023 - 2030, USD Million
- TABLE 29 North America Biodegradable Polymers Market by Country, 2019 - 2022, USD Million
- TABLE 30 North America Biodegradable Polymers Market by Country, 2023 - 2030, USD Million
- TABLE 31 North America Polymer-free Coating Market by Country, 2019 - 2022, USD Million
- TABLE 32 North America Polymer-free Coating Market by Country, 2023 - 2030, USD Million
- TABLE 33 North America Polymer-free Coating Market by Country, 2019 - 2022, Thousand Units
- TABLE 34 North America Polymer-free Coating Market by Country, 2023 - 2030, Thousand Units
- TABLE 35 North America Drug Eluting Stent Market by Polymer-free Coating Type, 2019 - 2022, USD Million
- TABLE 36 North America Drug Eluting Stent Market by Polymer-free Coating Type, 2023 - 2030, USD Million
- TABLE 37 North America Micro Porous Surface Market by Country, 2019 - 2022, USD Million
- TABLE 38 North America Micro Porous Surface Market by Country, 2023 - 2030, USD Million
- TABLE 39 North America Micro Structured Surface Market by Country, 2019 - 2022, USD Million
- TABLE 40 North America Micro Structured Surface Market by Country, 2023 - 2030, USD Million
- TABLE 41 North America Slotted Tubular Surface Market by Country, 2019 - 2022, USD Million
- TABLE 42 North America Slotted Tubular Surface Market by Country, 2023 - 2030, USD Million
- TABLE 43 North America Nanoporous Surface Market by Country, 2019 - 2022, USD Million
- TABLE 44 North America Nanoporous Surface Market by Country, 2023 - 2030, USD Million
- TABLE 45 North America Drug Eluting Stent Market by Country, 2019 - 2022, USD Million
- TABLE 46 North America Drug Eluting Stent Market by Country, 2023 - 2030, USD Million
- TABLE 47 North America Drug Eluting Stent Market by Country, 2019 - 2022, Thousand Units
- TABLE 48 North America Drug Eluting Stent Market by Country, 2023 - 2030, Thousand Units
- TABLE 49 US Drug Eluting Stent Market, 2019 - 2022, USD Million
- TABLE 50 US Drug Eluting Stent Market, 2023 - 2030, USD Million
- TABLE 51 US Drug Eluting Stent Market, 2019 - 2022, Thousand Units
- TABLE 52 US Drug Eluting Stent Market, 2023 - 2030, Thousand Units
- TABLE 53 US Drug Eluting Stent Market by Application, 2019 - 2022, USD Million
- TABLE 54 US Drug Eluting Stent Market by Application, 2023 - 2030, USD Million
- TABLE 55 US Drug Eluting Stent Market by Application, 2019 - 2022, Thousand Units
- TABLE 56 US Drug Eluting Stent Market by Application, 2023 - 2030, Thousand Units
- TABLE 57 US Drug Eluting Stent Market by Coating Type, 2019 - 2022, USD Million
- TABLE 58 US Drug Eluting Stent Market by Coating Type, 2023 - 2030, USD Million
- TABLE 59 US Drug Eluting Stent Market by Coating Type, 2019 - 2022, Thousand Units
- TABLE 60 US Drug Eluting Stent Market by Coating Type, 2023 - 2030, Thousand Units
- TABLE 61 US Drug Eluting Stent Market by Polymer-based Coating Type, 2019 - 2022, USD Million
- TABLE 62 US Drug Eluting Stent Market by Polymer-based Coating Type, 2023 - 2030, USD Million
- TABLE 63 US Drug Eluting Stent Market by Polymer-free Coating Type, 2019 - 2022, USD Million
- TABLE 64 US Drug Eluting Stent Market by Polymer-free Coating Type, 2023 - 2030, USD Million
- TABLE 65 Canada Drug Eluting Stent Market, 2019 - 2022, USD Million
- TABLE 66 Canada Drug Eluting Stent Market, 2023 - 2030, USD Million
- TABLE 67 Canada Drug Eluting Stent Market, 2019 - 2022, Thousand Units
- TABLE 68 Canada Drug Eluting Stent Market, 2023 - 2030, Thousand Units
- TABLE 69 Canada Drug Eluting Stent Market by Application, 2019 - 2022, USD Million
- TABLE 70 Canada Drug Eluting Stent Market by Application, 2023 - 2030, USD Million
- TABLE 71 Canada Drug Eluting Stent Market by Application, 2019 - 2022, Thousand Units
- TABLE 72 Canada Drug Eluting Stent Market by Application, 2023 - 2030, Thousand Units
- TABLE 73 Canada Drug Eluting Stent Market by Coating Type, 2019 - 2022, USD Million
- TABLE 74 Canada Drug Eluting Stent Market by Coating Type, 2023 - 2030, USD Million
- TABLE 75 Canada Drug Eluting Stent Market by Coating Type, 2019 - 2022, Thousand Units
- TABLE 76 Canada Drug Eluting Stent Market by Coating Type, 2023 - 2030, Thousand Units
- TABLE 77 Canada Drug Eluting Stent Market by Polymer-based Coating Type, 2019 - 2022, USD Million
- TABLE 78 Canada Drug Eluting Stent Market by Polymer-based Coating Type, 2023 - 2030, USD Million
- TABLE 79 Canada Drug Eluting Stent Market by Polymer-free Coating Type, 2019 - 2022, USD Million
- TABLE 80 Canada Drug Eluting Stent Market by Polymer-free Coating Type, 2023 - 2030, USD Million
- TABLE 81 Mexico Drug Eluting Stent Market, 2019 - 2022, USD Million
- TABLE 82 Mexico Drug Eluting Stent Market, 2023 - 2030, USD Million
- TABLE 83 Mexico Drug Eluting Stent Market, 2019 - 2022, Thousand Units
- TABLE 84 Mexico Drug Eluting Stent Market, 2023 - 2030, Thousand Units
- TABLE 85 Mexico Drug Eluting Stent Market by Application, 2019 - 2022, USD Million
- TABLE 86 Mexico Drug Eluting Stent Market by Application, 2023 - 2030, USD Million
- TABLE 87 Mexico Drug Eluting Stent Market by Application, 2019 - 2022, Thousand Units
- TABLE 88 Mexico Drug Eluting Stent Market by Application, 2023 - 2030, Thousand Units
- TABLE 89 Mexico Drug Eluting Stent Market by Coating Type, 2019 - 2022, USD Million
- TABLE 90 Mexico Drug Eluting Stent Market by Coating Type, 2023 - 2030, USD Million
- TABLE 91 Mexico Drug Eluting Stent Market by Coating Type, 2019 - 2022, Thousand Units
- TABLE 92 Mexico Drug Eluting Stent Market by Coating Type, 2023 - 2030, Thousand Units
- TABLE 93 Mexico Drug Eluting Stent Market by Polymer-based Coating Type, 2019 - 2022, USD Million
- TABLE 94 Mexico Drug Eluting Stent Market by Polymer-based Coating Type, 2023 - 2030, USD Million
- TABLE 95 Mexico Drug Eluting Stent Market by Polymer-free Coating Type, 2019 - 2022, USD Million
- TABLE 96 Mexico Drug Eluting Stent Market by Polymer-free Coating Type, 2023 - 2030, USD Million
- TABLE 97 Rest of North America Drug Eluting Stent Market, 2019 - 2022, USD Million
- TABLE 98 Rest of North America Drug Eluting Stent Market, 2023 - 2030, USD Million
- TABLE 99 Rest of North America Drug Eluting Stent Market, 2019 - 2022, Thousand Units
- TABLE 100 Rest of North America Drug Eluting Stent Market, 2023 - 2030, Thousand Units
- TABLE 101 Rest of North America Drug Eluting Stent Market by Application, 2019 - 2022, USD Million
- TABLE 102 Rest of North America Drug Eluting Stent Market by Application, 2023 - 2030, USD Million
- TABLE 103 Rest of North America Drug Eluting Stent Market by Application, 2019 - 2022, Thousand Units
- TABLE 104 Rest of North America Drug Eluting Stent Market by Application, 2023 - 2030, Thousand Units
- TABLE 105 Rest of North America Drug Eluting Stent Market by Coating Type, 2019 - 2022, USD Million
- TABLE 106 Rest of North America Drug Eluting Stent Market by Coating Type, 2023 - 2030, USD Million
- TABLE 107 Rest of North America Drug Eluting Stent Market by Coating Type, 2019 - 2022, Thousand Units
- TABLE 108 Rest of North America Drug Eluting Stent Market by Coating Type, 2023 - 2030, Thousand Units
- TABLE 109 Rest of North America Drug Eluting Stent Market by Polymer-based Coating Type, 2019 - 2022, USD Million
- TABLE 110 Rest of North America Drug Eluting Stent Market by Polymer-based Coating Type, 2023 - 2030, USD Million
- TABLE 111 Rest of North America Drug Eluting Stent Market by Polymer-free Coating Type, 2019 - 2022, USD Million
- TABLE 112 Rest of North America Drug Eluting Stent Market by Polymer-free Coating Type, 2023 - 2030, USD Million
- TABLE 113 Key Information - Abbott Laboratories
- TABLE 114 Key Information - Boston Scientific Corporation
- TABLE 115 Key Information - Terumo Corporation
- TABLE 116 Key Information - Medtronic PLC
- TABLE 117 Key Information - Biosensors International Group, Ltd.
- TABLE 118 Key Information - Cook Medical, Inc.
- TABLE 119 Key Information - B. Braun Melsungen AG
- TABLE 120 Key Information - Biotronik SE & Co. KG
- TABLE 121 Key Information - Lepu Medical Technology Co., Ltd
- TABLE 122 Key Information - Alvimedica
